Company Overview and News

59
'Safer' Dividend Dow Dogs: Intel, Chevron, DowDupont, McDonald's, And Boeing Cast Biggest Gains Per Broker September Targets

7m seekingalpha
24 of 30 Dow Industrial Index stocks were tagged as "safer" for dividends because they showed positive one-year returns and free cash-flow yields greater than their dividend yields 9/20/18.
CAT WBA UTX DWDP WMT VZA JNJ CVX CSCO VZ INTC PFE MCD CSCOI

38
Top 10 Net Payout Yields - September 2018

11h seekingalpha
The top net payout yield stocks had a 5.0% gain in August, outperforming the S&P 500 index.
NXT LBTY WBA NXPI CTL SYLD LBTYK KR LILAB AMAT CELG CSCO CSCOI EBAY GLW DFS C LBTYB LBTYA BBY MU LILAK QCOM LILA

20
3 MedTech Stocks for Safe Returns as Hurricane Fears Peak

2018-09-21 zacks
An upbeat economic scenario and strong growth in corporate earnings have encouraged investors to load up on U.S. stocks. The Dow Jones Industrial Average’s rise to an all-time high reflects the bullishness.
MASI QDEL BSX WBA ISRG UTX CVS MDT EOG

19
Dow, S&P 500 end at records as market shrugs off trade fights

2018-09-20 channelnewsasia
NEW YORK: The Dow and S&P 500 powered to fresh records on Thursday (Sep 20) as investors again shrugged off trade war worries.
GEC GE WEED WBA GNE CGC

16
Intel, Walgreens Push the Dow Higher Thursday

2018-09-20 247wallst
September 20, 2018: Markets opened higher again Thursday after which both the Dow and the S&P 500 indexes climbed to new all-time highs. Jobless claims fell last week to a level not seen in nearly 50 years and the Philadelphia Fed reported a near-doubling of its manufacturing index in September. Even tariff worries got buried. Energy was the only sector posting even a tiny loss Thursday as tech and consumer staples stocks were the day’s big gainers.
CATR CAT WBA INTC DWDP

18
The Ratings Game: The most bearish GE analyst gets even more bearish

2018-09-20 marketwatch
J.P. Morgan’s Stephen Tusa cut his stock price target by 9% to $10, which is the lowest of the 19 analysts surveyed by FactSet
GEC GE EXCU WBA GNE EXC

42
Stocks making the biggest move premarket: DRI, THO, GE, CAT, PG & more

2018-09-20 cnbc
Darden Restaurants – The parent of Olive Garden, Longhorn Steakhouse, and other restaurant chains earned $1.34 per share for its latest quarter, 10 cents a share above estimates. Revenue beat forecasts, as well. Darden's comparable-restaurant sales rose 3.3 percent, tripling consensus estimates, and it also raised its full-year outlook.
WFCNP RIO RIO RL WBA DRI SFIX RTPPF RTNTF DIS WFC GEC GE THO RHT RIO MLHR GNE

143
Stay-at-Home Stocks Find Favor With New Age Investors

2018-09-18 zacks
The past year has been tremendous for e-commerce giant Amazon (AMZN - Free Report) . The stock has gained a massive 96.8%, way ahead of the 15.8% rise of the S&P 500 Index. Online media giant Netflix (NFLX - Free Report) has surged 88.7%. Leading pizza delivery company, Domino’s Pizza (DPZ - Free Report) has risen 40.1% over the past year. On the contrary, retail drug store industry majors, Rite Aid (RAD - Free Report) and Walgreens Boots Alliance (WBA - Free Report) have witnessed a steep decline of 52.
HD TGT TXN RAD MDPEB WBA NFLX MDP

11
6 Monthly Dividend Stocks to Buy

2018-09-14 investorplace - 1
Most dividend stocks pay their shareholders quarterly, but a few dividend yielding stocks offer monthly distributions.
SJR.B WBA LTC SJRWF OPRF SJR.A KMI PAA KMR STAG CVB APLE O SJR FDX MAR HLT PBA KMRFZ

157
Fred’s Reports Second Quarter 2018 Results

2018-09-13 globenewswire - 2
MEMPHIS, Tenn., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Fred's, Inc. (NASDAQ: FRED) reported financial results for the second quarter and six months ended August 4, 2018.
FRED RAD WBA

7
Boeing, Caterpillar Prop Up the Dow Wednesday

2018-09-12 247wallst
September 12, 2018: Markets opened mixed Wednesday and none of the major indexes strayed to far from the break-even line. Today brought the introduction of new hardware from Apple, an event about which more pixels are burned than perhaps any other. The Fed Beige Book also rolled out today with a lot of attention paid to energy. Consumer staples and energy are the day’s best performing staples while financial services and tech stocks lagged.
PG CATR CAT BOE WBA BA

3
Is Walgreens Stock Bound for Another Earnings Beat?

2018-09-12 investorplace
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Walgreens Boots Alliance (NASDAQ:WBA), which belongs to the Zacks Retail – Pharmacies and Drug Stores industry, could be a great candidate to consider. After all, Walgreens stock has benefited from a nice streak of beating earnings estimates, especially when looking at the previous two reports.
WBA

3
Why Walgreens (WBA) Could Beat Earnings Estimates Again

2018-09-12 zacks
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Walgreens Boots Alliance (WBA - Free Report) , which belongs to the Zacks Retail - Pharmacies and Drug Stores industry, could be a great candidate to consider.
WBA

199
Aetna Stock Should Have More Upside, But There’s One Key Risk

2018-09-12 investorplace
Aetna (NYSE:AET) stock has soared of late, for two key reasons. First, a takeout of Aetna stock by CVS (NYSE:CVS) appears increasingly likely to pass regulatory muster. Secondly, CVS stock, a component of the consideration paid for AET stock, has gained, increasing the value of the offer.
FRED AMZN RAD WBA CVS AET

31
A Home Run For Fred's: Now Management Needs To Wind Down The Business

2018-09-11 seekingalpha
The management team at Fred's announced a large and exciting sale for shareholders in the company.
FRED WBA CVS

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to WBA / Walgreens Boots Alliance, Inc. on message board site Silicon Investor.

Walgreen Boots Alliance - WBA Walgreen Boots Alliance - WBA Walgreen Boots Alliance - WBA Snowball.com, Inc. (Nasdaq - SNOW) Snowball.com, Inc. (Nasdaq - SNOW) Snowball.com, Inc. (Nasdaq - SNOW)
CUSIP: 931427108